Abstract

Pulmonary edema, characterized by the accumulation of fluid in the alveolar and interstitial spaces of the lungs, is a critical condition that can result from various pathologies, including heart failure, acute respiratory distress syndrome, and renal dysfunction. This article reviews recent advancements in the management of pulmonary edema, focusing on current treatment strategies and exploring future directions. We discuss pharmacological interventions, non-pharmacological therapies, and emerging technologies. The integration of novel approaches such as precision medicine and targeted therapies holds promise for improving patient outcomes. Understanding these advances is crucial for clinicians aiming to enhance the management and prognosis of patients with pulmonary edema.